BOOTHBAY FUND MANAGEMENT, LLC - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 88 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,033,000
+249.0%
45,000
+309.1%
0.09%
+109.3%
Q4 2018$296,00011,0000.04%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$9,074,0001.96%
NEA Management Company, LLC 4,912,306$49,025,0000.99%
RA Capital Management 4,871,067$48,613,0000.86%
Samsara BioCapital, LLC 345,293$3,446,0000.67%
Endurant Capital Management LP 197,462$1,971,0000.48%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,867,467$18,637,0000.39%
ACT CAPITAL MANAGEMENT, LLC 27,500$274,0000.20%
Baker Brothers Advisors 3,863,239$38,555,0000.19%
Rock Springs Capital Management LP 627,180$6,259,0000.14%
Aquatic Capital Management LLC 4,000$40,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders